Armodafinil for treatment of excessive sleepiness associated with shift work disorder: A randomized controlled study

Mayo Clinic Proceedings

Volumn 84, Issue 11, 2009, Pages 958-972

  Czeisler, Charles A ^a,b   Walsh, James K ^c   Wesnes, Keith A ^d   Arora, Sanjay ^f   Roth, Thomas ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ST LUKE S HOSPITAL   (United States)

^d Henry Ford Hospital ^*  (United Kingdom)

^e HENRY FORD HOSPITAL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; PLACEBO;

ADULT; AGED; ANXIETY; ARTICLE; ATTENTION; BEDTIME DOSAGE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INSOMNIA; LONG TERM MEMORY; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTICENTER STUDY; NAUSEA; NIGHT SLEEP; NIGHT WORK; NORTH AMERICA; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SHIFT WORK DISORDER; SHIFT WORKER; SIDE EFFECT; SLEEP DISORDER; SLEEP PATTERN; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT DURATION; VIRUS MENINGITIS; WAKEFULNESS;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; MINNESOTA; POLYSOMNOGRAPHY; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS, CIRCADIAN RHYTHM; STATISTICS, NONPARAMETRIC; TASK PERFORMANCE AND ANALYSIS; TREATMENT OUTCOME; WORK SCHEDULE TOLERANCE; YOUNG ADULT;

EID: 71249151530     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.11.958     Document Type: Article

References (52)

1. Bureau of Labor Statistics. Workers on Flexible and Shift Schedules in 2004 Summary. http://www.bls.gov/news.release/flex.nr0.htm. Accessed August 25, 2009.
2. Åkerstedt T. Shift work and disturbed sleep/wakefulness. Occup Med (Lond). 2003;53(2):89-94.
3. Richardson GS, Malin HV. Circadian rhythm sleep disorders: pathophysiology and treatment. J Clin Neurophysiol. 1996;13(1):17-31. (Pubitemid 26005162)
4. Drake CL, Roehrs T, Richardson G, Walsh JK, Roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004;27(8):1453-1462. (Pubitemid 40041612)
5. Torsvall L, Åkerstedt T, Gillander K, Knutsson A. Sleep on the night shift: 24-hour EEG monitoring of spontaneous sleep/wake behavior. Psychophysiology. 1989;26(3):352-358. (Pubitemid 19162448)
6. Åkerstedt T. Shift work and sleep disorders [editorial]. Sleep. 2005; 28(1):9-11.
7. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
9. Gold DR, Rogacz S, Bock N, et al. Rotating shift work, sleep, and accidents related to sleepiness in hospital nurses. Am J Public Health. 1992; 82(7):1011-1014.
10. Mitler MM, Miller JC, Lipsitz JJ, Walsh JK, Wylie CD. The sleep of long-haul truck drivers. N Engl J Med. 1997;337(11):755-761.
11. Knutsson A. Health disorders of shift workers. Occup Med (Lond). 2003;53(2):103-108.
12. Ohayon MM, Lemoine P, Arnaud-Briant V, Dreyfus M. Prevalence and consequences of sleep disorders in a shift worker population. J Psychosom Res. 2002;53(1):577-583. (Pubitemid 34884469)
13. Segawa K, Nakazawa S, Tsukamoto Y, et al. Peptic ulcer is prevalent among shift workers. Dig Dis Sci. 1987;32(5):449-453. (Pubitemid 17071222)
14. Akerstedt T. Work hours, sleepiness and accidents: introduction and summary. J Sleep Res. 1995;4(suppl 2):1-3. (Pubitemid 26025912)
15. Smith L, Folkard S, Poole CJ. Increased injuries on night shift. Lancet. 1994;344(8930):1137-1139.
16. Czeisler CA, Walsh JK, Roth T, et al; U.S. Modafinil in Shift Work Sleep Disorder Study Group. Modafinil for excessive sleepiness associated with shift-work sleep disorder [published correction appears in N Engl J Med. 2005;353(10):1078]. N Engl J Med. 2005;353(5):476-486.
17. Dinges DF, Arora S, Darwish M, Niebler GE. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin. 2006;22(1):159-167. (Pubitemid 43106919)
18. Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised, 1976. Rockville, MD: US Dept of Health and Human Services; 1976.
19. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9(4):519-524.
20. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Vol Publication 204. Washington, DC: National Institutes of Health; 1968.
21. Mitler MM, Carskadon MA, Hirshkowitz M. Evaluating sleepiness. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:1417-1423.
22. Gillberg M, Kecklund G, Akerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep. 1994; 17(3):236-241. (Pubitemid 24174455)
23. Keith MS, Stanislav SW, Wesnes KA. Validity of a cognitive computerized assessment system in brain-injured patients. Brain Inj. 1998;12(12): 1037-1043.
24. Wesnes KA, McKeith IG, Ferrara R, et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebocontrolled international study using the Cognitive Drug Research computerised assessment system. Dement Geriatr Cogn Disord. 2002;13(3):183-192. (Pubitemid 34224938)
25. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl). 2000;152(4):353-361.
26. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB. The clinical use of the MSLT and MWT. Sleep. 2005;28(1):123-144.
27. Modafinil US in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol. 1998;43(1):88-97.
28. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163(5):565-571. (Pubitemid 36314343)
29. Littner M, Johnson SF, McCall WV, et al; Standards of Practice Committee. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep. 2001;24(4):451-466.
30. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006; 29(3):375-380. (Pubitemid 44019961)
31. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22(6):757-765. (Pubitemid 29445343)
32. Siccoli MM, Pepperell JC, Kohler M, Craig SE, Davies RJ, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep. 2008;31(11):1551-1558.
33. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27(3):453-458. (Pubitemid 44138805)
34. Douglas NJ, Engleman HM. Effects of CPAP on vigilance and related functions in patients with the sleep apnea/hypopnea syndrome. Sleep. 2000;23(suppl 4):S147-S149. (Pubitemid 30462673)
35. Punjabi NM, Bandeen-Roche K, Young T. Predictors of objective sleep tendency in the general population. Sleep. 2003;26(6):678-683. (Pubitemid 39619777)
36. Durmer J, Dinges D. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117-129.
37. Dawson D, Reid K. Fatigue, alcohol and performance impairment [letter]. Nature. 1997;388(6639):235. (Pubitemid 27317957)
38. Pilcher JJ, Huffcutt AI. Effects of sleep deprivation on performance: a meta-analysis. Sleep. 1996;19(4):318-326. (Pubitemid 26157501)
39. Roehrs T, Greenwald M, Roth T. Risk-taking behavior: effects of ethanol, caffeine, and basal sleepiness. Sleep. 2004;27(5):887-893. (Pubitemid 39095720)
40. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation [published correction appears in Sleep. 2004;27(4):600]. Sleep. 2003;26(2):117-126.
41. Dinges DF, Pack F, Williams K, et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep. 1997;20(4):267-277. (Pubitemid 27276641)
42. Barger LK, Cade BE, Ayas NT, et al; Harvard Work Hours, Health, and Safety Group. Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med. 2005;352(2):125-134.
43. Findley L, Unverzagt M, Guchu R, Fabrizio M, Buckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest. 1995;108(3):619-624.
44. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep. 1989;12(6):487-494. (Pubitemid 20009376)
45. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest. 1996;109(6):1470-1476. (Pubitemid 26193370)
46. Krieger J, Meslier N, Lebrun T, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. Chest. 1997;112(6):1561-1566. (Pubitemid 28007763)
47. Ayas NT, Barger LK, Cade BE, et al. Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA. 2006;296(9):1055-1062.
48. Barger LK, Ayas NT, Cade BE, et al. Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med. 2006;3(12):e487.
49. Landrigan CP, Rothschild JM, Cronin JW, et al. Effect of reducing interns' work hours on serious medical errors in intensive care units. N Engl J Med. 2004;351(18):1838-1848.
50. Lockley SW, Cronin JW, Evans EE, et al; Harvard Work Hours, Health, and Safety Group. Effect of reducing interns' weekly work hours on sleep and attentional failures. N Engl J Med. 2004;351(18):1829-1837.
51. Harsh JR, Hayduk R, Rosenberg R, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin. 2006;22(4):761-774.
52. Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther. 2006;28(5):689-706. (Pubitemid 44067263)